Evidence map›Paper›PMID 42290720›Full record

ArticleFrontiers in pediatrics2026

Analysis of influencing factors for progression from type 2 to type 1 in retinopathy of prematurity.

Shuyuan Zhang, Xingyue Chen, Jing Su, Wenfang Ye, Huan Ding, Kaiyan Zhang

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shuyuan ZhangDepartment of Ophthalmology, Hainan Affiliated Hospital of Hainan Medical University (Hainan General Hospital), Haikou, Hainan, China.
Xingyue ChenDepartment of Neonatology, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, Hainan, China.
Jing SuSchool of Public Health, Hainan Medical University, Haikou, Hainan, China.
Wenfang YeDepartment of Ophthalmology, Hainan Affiliated Hospital of Hainan Medical University (Hainan General Hospital), Haikou, Hainan, China.
Huan DingDepartment of Ophthalmology, Hainan Affiliated Hospital of Hainan Medical University (Hainan General Hospital), Haikou, Hainan, China.
Kaiyan ZhangDepartment of Ophthalmology, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, Hainan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate factors associated with the progression of Retinopathy of Prematurity(ROP). Methods: A retrospective analysis was performed on 148 ROP infants. All cases were classified into type 1 and type 2 ROP according to the ETROP criteria, and those progressing from type 2 to type 1 were defined as progressive type (prog-type). Intergroup differences and relevant factors for prog-type were analyzed. Results: Among the 148 infants with ROP, 31 (20.9%) were type 1 ROP, 91 (61.5%) were type 2 ROP, and 26 (17.6%) were prog-type. Univariate analyses revealed significant differences among the three groups in gestational age (GA), birth weight(BW), delivery mode, 5-min Apgar score, hood/nasal cannula oxygen therapy(HH/MNCO) duration, non-invasive ventilation(NIV) duration, and presence of bronchopulmonary dysplasia(BPD) (all Conclusion: Different ROP groups exhibit distinct clinical characteristics. Lower GA, low BW, prolonged NIV and BPD were correlated with prog-type. Among C-section infants, prog-type was less common than type 1, whereas type 2 was more common than type 1. After multinomial adjustment, GA and HH/MNCO duration remained independently associated with prog-type, which may help clinical risk assessment and individualized intervention.

Indexed as

factorspreterm infantsretinopathy of prematuritytype 1 ROPtype 2 ROP

Identifiers

PMID42290720
PMCPMC13254827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.